Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum YM BioSciences Inc YMI

NYSEAM:YMI - Post Discussion

YM BioSciences Inc > Anybody else wondering
View:
Post by Jenser on Jun 15, 2010 12:54pm

Anybody else wondering

why the high volume and volatility today? GMP did some dumping yesterday and today to finally cross 677200 shares at 1.23. There are three milestones due at Q2/2010. This thing is popping in the wrong direction so far.
Comment by oexel on Jun 15, 2010 2:52pm
Other interesting thing is that the volume on the tsx today is twice that of on the nasdaq.  I guess it's just a canadian side investor getting out for whatever reason.  I think if bad news was imminent you'd see shares being dumped on both sides
Comment by smokeyjoe on Jun 15, 2010 5:57pm
Man, I sure hope you're right!   I bought in at $1.40, and have been regretting it ever since.  Let's hope the new director can reverse ships.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities